GoLiver Therapeutics announces that it has won the “Innovations in Biotherapies and Bioproduction” call for proposal launched by the French government to make France a European leader in the biotherapy sector. The start-up will receive a EUR 1.6 million investment from France 2030.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBU:
- Vir Biotechnology appoints Jason O’Byrne as CFO
- Caribou treatment of acute myeloid leukemia designated for FDA orphan status
- Caribou Biosciences Announces CFO Resignation and Succession Plan
- Caribou Biosciences CFO Jason O’Byrne resigns
- Caribou Biosciences says FDA grants Fast Track designations to CB-010